Search

everythinglearnresearchcommunity

for

Search:↓

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Lower SMAD2/3 activation predicts more severe skin cancer.

Deleting TNFα gene reduces skin cancer risk in certain mice.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

3D virtual planning can help in precise skull reconstruction for advanced skin cancer, but patient-specific factors must be considered.

A rare skin tumor with extra hair growth was found and safely removed from a 27-year-old woman.

Clouston syndrome can lead to skin cancer, so monitoring is crucial.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Electrochemotherapy successfully treated skin tumors in cats without recurrence.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Understanding factors affecting recurrence and survival can improve treatment for head and neck skin cancer.

Skin cancer in sun-exposed areas is more likely to come back.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

UVB exposure affects retinoid metabolism, which is important for skin cancer progression and treatment.